BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33320715)

  • 21. Head-to-head comparison between
    Heimburger C; Veillon F; Taïeb D; Goichot B; Riehm S; Petit-Thomas J; Averous G; Cavalcanti M; Hubelé F; Chabrier G; Namer IJ; Charpiot A; Imperiale A
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):979-987. PubMed ID: 28050631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
    Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
    Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET-CT imaging in head and neck paragangliomas: A centre experience.
    Boughdad S; O'Connor A; Cook GJ; Pike L; Connor S; Obholzer R; Warbey V
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):315-322. PubMed ID: 33598922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [
    Ohtake M; Tateishi K; Murata H; Nagashima Y; Yamanaka S; Yamamoto T
    World Neurosurg; 2018 Jun; 114():47-52. PubMed ID: 29510284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phenotype of
    Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
    Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimodal (18)F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier.
    Treglia G; Ruberto T; Giovanella L
    Endocrine; 2016 May; 52(2):397-8. PubMed ID: 25860886
    [No Abstract]   [Full Text] [Related]  

  • 30. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
    Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
    J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
    Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
    J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head and neck paragangliomas: clinical and molecular genetic classification.
    Offergeld C; Brase C; Yaremchuk S; Mader I; Rischke HC; Gläsker S; Schmid KW; Wiech T; Preuss SF; Suárez C; Kopeć T; Patocs A; Wohllk N; Malekpour M; Boedeker CC; Neumann HP
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):19-28. PubMed ID: 22584701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and to define their diagnostic roles in current scenario.
    Arora S; Kumar R; Passah A; Tripathi M; Agarwala S; Khadgawat R; Bal C
    Nucl Med Commun; 2019 Dec; 40(12):1230-1242. PubMed ID: 31633647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by
    van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM
    J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.
    Nockel P; El Lakis M; Gaitanidis A; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Ann Surg; 2019 Apr; 269(4):741-747. PubMed ID: 29334561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetics of paragangliomas.
    Burnichon N; Abermil N; Buffet A; Favier J; Gimenez-Roqueplo AP
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Dec; 129(6):315-8. PubMed ID: 23078982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of
    Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
    Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.